Can circulating oxidative stress-related biomarkers be used as an early prognostic marker for COVID-19?

Sadeleştirilmiş öğe sayfası
dc.contributor.authorUysal, Pelin
dc.contributor.authorYuksel, Arzu
dc.contributor.authorDurmus, Sinem
dc.contributor.authorCuhadaroglu, Caglar
dc.contributor.authorGelisgen, Remise
dc.contributor.authorUzun, Hafize
dc.date.accessioned2025-10-16T15:15:57Z
dc.date.issued2023
dc.identifier.doi10.3389/fmed.2023.1041115
dc.identifier.otherWOS:000936105300001
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/6579
dc.publisherFRONTIERS MEDIA SA
dc.sourceFRONTIERS IN MEDICINE
dc.subjectCOVID\\-19
dc.subjectnuclear factor kappa B
dc.subjectlipid metabolism
dc.subjectoxidized LDL
dc.subjectlectin\\-like oxidized\\-LDL receptor\\-1
dc.titleCan circulating oxidative stress-related biomarkers be used as an early prognostic marker for COVID-19?
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS